Zongqiang Wang

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Acinetobacter Baumannii

Top Venues

Nature communications

Organic letters

Angewandte Chemie (International ed. in English)

ACS infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Adam F Rosenzweig, Zongqiang Wang, Adrián Morales-Amador, Kaylyn Spotton, Sean F Brady
A Family of Antibiotics That Evades Resistance by Binding Polyprenyl Phosphates. ACS infectious diseases (2023)
Zongqiang Wang, Bimal Koirala, Yözen Hernández, Matthew D Zimmerman, Sean F Brady
Bioinformatic prospecting and synthesis of a bifunctional lipopeptide antibiotic that evades resistance. Science (New York, N.Y.) 376 (6596) (2022)
Zongqiang Wang, Nicholas Forelli, Yözen Hernández, Melinda A Ternei, Sean F Brady
Lapcin, a potent dual topoisomerase I/II inhibitor discovered by soil metagenome guided total chemical synthesis. Nature communications 13 (1) (2022)
Zongqiang Wang, Bimal Koirala, Yözen Hernández, Sean F Brady
Discovery of Paenibacillaceae Family Gram-Negative-Active Cationic Lipopeptide Antibiotics Using Evolution-Guided Chemical Synthesis. Organic letters 24 (27) (2022)
Zongqiang Wang, Bimal Koirala, Yözen Hernández, Matthew Zimmerman, Steven Park, David S Perlin, Sean F Brady
A naturally inspired antibiotic to target multidrug-resistant pathogens. Nature 601 (7894) (2022)
Vincent K Libis, Logan W MacIntyre, Rabia Mehmood, Liliana Guerrero, Melinda A Ternei, Niv Antonovsky, Ján Burian, Zongqiang Wang, Sean F Brady
Multiplexed mobilization and expression of biosynthetic gene clusters. Nature communications 13 (1) (2022)
Zongqiang Wang, Amanda Kasper, Rabia Mehmood, Melinda Ternei, Shaogang Li, Joel S Freundlich, Sean F Brady
Metagenome-Guided Analogue Synthesis Yields Improved Gram-Negative-Active Albicidin- and Cystobactamid-Type Antibiotics. Angewandte Chemie (International ed. in English) 60 (41) (2021)